Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 07:35 ET | Source: Urteste S.A.

Urteste S.A. launches European multicenter clinical study of the Panuri test

Urteste S.A. launches European multicenter clinical study of the Panuri test Gdańsk, Poland – 6 November 2025 – Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in the development...
October 22, 2025 14:26 ET | Source: BCC Research LLC

Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030

Boston, Oct. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Molecular Diagnostics: Technologies and Global Markets” is projected to grow from $23 billion in 2025 to...
September 22, 2025 08:00 ET | Source: Onconetix, Inc.

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and...
September 19, 2025 08:30 ET | Source: Advanced Biomed Inc.

Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery

[Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing...
July 29, 2025 13:08 ET | Source: BCC Research LLC

Colonoscopes: Global Markets Surge as Colorectal Cancer Screening Takes Center Stage

Boston, July 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Colonoscopes: Global Markets” is projected to reach $3.4 billion by the end of 2030, growing at a CAGR of...
July 21, 2025 08:14 ET | Source: Urteste S.A.

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company...
June 17, 2025 14:02 ET | Source: BCC Research LLC

Radiopharmaceuticals Market Set to Grow with 16.4% CAGR from 2024 to 2029

Boston, June 17, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Radiopharmaceuticals: Technologies and Global Markets” is expected to grow from $10.3 billion in 2024...
June 02, 2025 07:00 ET | Source: InStride

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
March 27, 2025 11:21 ET | Source: Urteste S.A.

Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025

27 MARCH 2025 PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, Poland – 27 March 2025 – Urteste S.A. (Warsaw Stock...
March 11, 2025 19:30 ET | Source: FACT.MR

Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035

Rockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a...